KEGG: hin:HI1115
STRING: 71421.HI1115
HI_1115 is a full-length (167 amino acids) thioredoxin-like protein from Haemophilus influenzae with the amino acid sequence: MKIKKLLKNGLSLFLTFIVITSILDFVRRPVVPEEINKITLQDLQGNTFSLESLDQNKPT LLYFWGTWCGYCRYTSPAINSLAKEGYQVVSVALRSGNEADVNDYLSKNDYHFTTVNDPK GEFAERWQINVTPTIVLLSKGKMDLVTTGLTSYWGLKVRLFFAEFFG . The protein contains the characteristic thioredoxin fold with a WCGYCR motif that is essential for its thiol-disulfide exchange activity .
The HI_1115 protein contains the highly conserved WCGYCR active site motif (residues 62-67) that is characteristic of thioredoxin family proteins . This region forms the catalytic center for thiol-disulfide exchange reactions. Unlike classical thioredoxins that typically have a WCGPC motif, HI_1115's WCGYCR variation suggests potential functional specialization. The protein likely maintains the canonical thioredoxin fold consisting of a central core of β-sheets surrounded by α-helices, similar to other thioredoxin family proteins that catalyze redox reactions through reversible oxidation of their active site dithiol .
For optimal expression of recombinant HI_1115 in E. coli, consider the following methodological approach:
Vector selection: Balance copy number and promoter strength to minimize metabolic burden. High-copy plasmids (pMB1'-derived, 500-700 copies/cell) with moderate promoters or moderate-copy plasmids (p15A, ~10 copies/cell) with stronger promoters (like T7) can be effective .
Expression strain: BL21(DE3) is recommended for T7 promoter-based expression as it contains the T7 RNA polymerase gene and lacks lon and ompT proteases .
Induction conditions:
Temperature: 25-30°C post-induction often improves solubility
IPTG concentration: 0.1-0.5 mM for moderate induction
Induction time: 4-6 hours or overnight at lower temperatures
Media composition: Rich media (LB, TB) supplemented with glucose (0.5-1%) to prevent leaky expression and additional amino acids may enhance protein yield .
This balanced approach prevents the negative effects of metabolic burden observed when high-copy vectors with strong promoters are used, which can decrease recombinant protein yields .
A multi-step purification strategy is recommended to achieve high purity and maintain activity:
Affinity chromatography: For His-tagged HI_1115, use Ni-NTA agarose columns with the following buffer system:
Size exclusion chromatography: Further purification using Superdex 75 in 20 mM Tris-HCl pH 8.0, 150 mM NaCl to remove aggregates and contaminants.
Storage considerations: Store in Tris/PBS-based buffer with 50% glycerol at -20°C/-80°C. For working aliquots, store at 4°C for up to one week to avoid repeated freeze-thaw cycles which can compromise activity .
Protein purity should be assessed by SDS-PAGE (>90% purity is achievable) and activity should be confirmed using thioredoxin activity assays .
The redox activity of HI_1115 can be measured using several complementary approaches:
Method 1: DTNB Reduction Assay
This colorimetric assay measures the rate of reduction of 5,5'-dithiobis-(2-nitrobenzoic acid) (DTNB) by thioredoxin:
Reaction mixture (1 mL):
100 mM potassium phosphate buffer, pH 7.0
2 mM EDTA
0.2 mM NADPH
0.1 mM DTNB
Appropriate thioredoxin reductase (0.2 μM)
Purified HI_1115 (varying concentrations)
Measurement: Monitor the increase in absorbance at 412 nm over time. The rate of TNB formation (ε₄₁₂ = 13,600 M⁻¹cm⁻¹) corresponds to the thioredoxin activity.
Controls: Include reactions with known thioredoxin inhibitors to distinguish specific activity .
Method 2: Insulin Disulfide Reduction Assay
This assay measures the ability of HI_1115 to reduce insulin disulfide bonds:
Reaction mixture:
100 mM potassium phosphate, pH 7.0
2 mM EDTA
0.13 mM insulin
1 mM DTT
Purified HI_1115
Measurement: Monitor the increase in turbidity at 650 nm due to the precipitation of the free insulin B chain .
A standard activity curve should be prepared using known concentrations of a reference thioredoxin to ensure accurate quantification .
To identify physiological protein targets of HI_1115, several complementary approaches can be employed:
In Vivo Single-Cysteine Mutant Approach:
Generate a monocysteinic His-tagged HI_1115 mutant by substituting the resolving cysteine (likely Cys65 in the WCGYCR motif) with serine.
Express this mutant in H. influenzae under physiological conditions.
Extract proteins and purify using Ni-NTA chromatography.
Elute covalently linked target proteins with DTT.
Transformed Recombinant Enrichment Profiling (TREP):
This technique uses natural transformation to generate pools of recombinants, followed by phenotypic selection and deep sequencing:
Transform H. influenzae with DNA containing HI_1115 variants.
Select for phenotypes of interest.
Use deep sequencing to identify genetic variants associated with the phenotype .
Reductome Approach:
Treat cell extracts with NEM to block free thiols.
Add recombinant HI_1115 and DTT to reduce target proteins.
Label newly exposed thiols with biotin-maleimide.
Purify biotinylated proteins and identify by mass spectrometry .
The identified targets should be validated through direct binding assays and functional studies to confirm physiological relevance.
While the specific role of HI_1115 in H. influenzae virulence has not been fully characterized, thioredoxin-like proteins generally contribute to bacterial pathogenesis through several mechanisms:
Oxidative stress defense: HI_1115 likely helps H. influenzae counter the oxidative burst from host immune cells by maintaining the reduced state of critical proteins. This function is particularly important during invasion and survival within epithelial cells and against neutrophil-mediated killing .
Protein repair and homeostasis: By reducing inappropriate disulfide bonds formed during oxidative stress, HI_1115 may preserve the function of key virulence factors and metabolic enzymes required for infection.
Potential interactions with host proteins: Like other bacterial thioredoxins, HI_1115 might interact with host proteins, potentially modifying host signaling pathways or redox-dependent processes. For example, H. influenzae uses surface proteins like Hsf to acquire host vitronectin, inhibiting complement activation and promoting intracellular invasion .
Contribution to intracellular survival: Studies have identified H. influenzae factors like HMW1 that contribute to intracellular invasion and persistence during chronic infection. As a redox-active protein, HI_1115 potentially supports this process by helping bacteria cope with the intracellular environment .
Experimental approaches to verify these roles include creating HI_1115 knockout mutants and assessing their virulence in cellular infection models and animal studies.
The interaction between HI_1115 and the host immune system likely involves several mechanisms, though direct evidence specific to HI_1115 is limited:
Redox modulation of immune responses: As a thioredoxin-like protein, HI_1115 may contribute to modifying the redox environment at the host-pathogen interface. Many immune processes like neutrophil extracellular trap (NET) formation, inflammasome activation, and cytokine signaling are redox-sensitive.
Protection against oxidative killing: During phagocytosis, H. influenzae encounters reactive oxygen species. HI_1115 likely participates in the bacterial defense system that neutralizes these oxidants and maintains the function of essential bacterial proteins .
Potential role in biofilm formation: Biofilms provide protection against immune clearance, and redox regulation by thioredoxin-like proteins has been implicated in biofilm formation in other bacteria.
Indirect effects through bacterial fitness: By maintaining the redox homeostasis of the bacterium, HI_1115 helps sustain the expression and function of direct virulence factors such as adhesins and invasins that engage with host immune components .
Research approaches to characterize these interactions include using recombinant HI_1115 in immune cell stimulation assays, comparing wild-type and HI_1115 mutant strains for survival in human serum, and assessing immune responses in infection models.
When designing experiments to study HI_1115 activity, the following controls are essential:
Positive Controls:
Commercial thioredoxin with known activity (e.g., E. coli Trx1)
Pre-reduced HI_1115 sample to establish maximum activity baseline
Negative Controls:
Heat-inactivated HI_1115 (95°C for 10 minutes)
Catalytic cysteine mutant (C62S in the WCGYCR motif)
Reaction mixture without HI_1115
Specificity Controls:
Thioredoxin inhibitors (e.g., PX-12 or auranofin) to confirm activity is thioredoxin-specific
Non-redox related protein of similar size and charge
Buffer-only control to account for spontaneous reactions
System Controls:
Varying substrate concentrations to establish Km and Vmax
pH range tests (typically pH 6.0-8.0) to determine optimal conditions
Time course measurements to ensure linearity of the reaction
Data Recording Format:
Record your data in a structured table format like this:
| Sample | Substrate Conc. (μM) | Temperature (°C) | pH | Activity (nmol/min/mg) | % Control Activity |
|---|---|---|---|---|---|
| HI_1115 (1 μg) | 100 | 25 | 7.0 | [measured] | 100 |
| + Inhibitor | 100 | 25 | 7.0 | [measured] | [calculated] |
| Heat-inactivated | 100 | 25 | 7.0 | [measured] | [calculated] |
| Catalytic mutant | 100 | 25 | 7.0 | [measured] | [calculated] |
This comprehensive control set ensures your results accurately reflect HI_1115-specific activity and helps identify potential experimental artifacts .
To investigate potential synergistic interactions between HI_1115 and other redox proteins in H. influenzae, a systematic experimental design approach is necessary:
1. Proteomics-based interaction screening:
Employ affinity-based techniques with single-cysteine HI_1115 mutants to trap interacting proteins
Use crosslinking mass spectrometry to capture transient interactions
Conduct co-immunoprecipitation experiments followed by mass spectrometry analysis
2. Functional interaction assays:
Design a 3×3 factorial experiment testing combinations of purified HI_1115 with other redox proteins:
| Experiment | HI_1115 | Protein X | Protein Y | Expected Outcome if Synergistic |
|---|---|---|---|---|
| 1 | Present | Absent | Absent | Baseline HI_1115 activity |
| 2 | Absent | Present | Absent | Baseline Protein X activity |
| 3 | Absent | Absent | Present | Baseline Protein Y activity |
| 4 | Present | Present | Absent | Activity > sum of individual components |
| 5 | Present | Absent | Present | Activity > sum of individual components |
| 6 | Absent | Present | Present | Activity > sum of individual components |
| 7 | Present | Present | Present | Complex interaction pattern |
| 8 | Absent | Absent | Absent | Background level (negative control) |
Measure relevant endpoints such as:
3. Genetic approach:
Generate single, double, and triple gene knockouts in H. influenzae
Measure phenotypic outcomes such as:
Sensitivity to oxidative stress (H₂O₂, paraquat)
Virulence in cell culture models
Metabolic fitness under various conditions
Complement with wild-type and mutant variants to confirm specificity
4. Structural biology approach:
Use protein-protein docking simulations to predict interaction interfaces
Confirm predictions using site-directed mutagenesis of predicted interface residues
Employ NMR or X-ray crystallography to solve structures of protein complexes
This multi-faceted approach will provide comprehensive evidence of functional interactions between HI_1115 and other redox proteins, potentially revealing new aspects of redox homeostasis in H. influenzae .
Recombinant HI_1115 can serve as a foundation for developing novel antimicrobial strategies through several approaches:
1. Target-based drug discovery:
Use purified recombinant HI_1115 for high-throughput screening of compound libraries
Identify small molecules that selectively inhibit HI_1115 activity
Perform structure-activity relationship (SAR) studies to optimize lead compounds
Verify efficacy of inhibitors against H. influenzae growth and virulence in vitro and in vivo
2. Structure-based drug design:
Solve the crystal structure of HI_1115 using X-ray crystallography
Identify unique structural features distinct from human thioredoxins
Use computational approaches to design selective inhibitors targeting these differences
Synthesize and test candidate molecules in enzyme and cellular assays
3. Immunological approaches:
Develop antibodies against surface-exposed epitopes of HI_1115
Test antibody-mediated neutralization of HI_1115 activity
Assess potential for vaccine development using recombinant HI_1115 as an antigen
Evaluate protection in animal models of H. influenzae infection
4. Combination therapy strategies:
Determine if HI_1115 inhibition sensitizes H. influenzae to oxidative stress or antibiotics
Design combination approaches targeting multiple redox systems simultaneously
Test synergistic effects in antibiotic-resistant H. influenzae strains
Experimental validation table:
| Strategy | Initial Screening | Secondary Validation | In vivo Confirmation |
|---|---|---|---|
| HI_1115 inhibitors | Enzyme activity assays with recombinant protein | Growth inhibition of H. influenzae cultures | Mouse infection models |
| Antibody development | ELISA binding assays | Neutralization of HI_1115 activity | Protection studies |
| Vaccine potential | Immunization studies | Antibody titer measurements | Challenge studies |
| Combination approaches | Checkerboard assays with antibiotics | Time-kill studies | Reduced bacterial load in tissues |
These approaches leverage recombinant HI_1115 as both a target and a tool for developing strategies that could overcome antibiotic resistance by exploiting bacterial redox vulnerabilities .
Studying the evolutionary conservation of HI_1115 across Haemophilus species and other respiratory pathogens presents several methodological challenges:
1. Sequence acquisition and alignment challenges:
Incomplete genome annotations in many Haemophilus strains
Presence of paralogous thioredoxin-like proteins confounding orthology assignment
Varying nomenclature across databases hindering identification of true orthologs
Low sequence conservation outside the active site complicating meaningful alignments
Approach: Use sensitive profile-based search methods (PSI-BLAST, HMM profiles) rather than simple BLAST. Employ phylogeny-aware multiple sequence alignment algorithms like MUSCLE or MAFFT with iterative refinement.
2. Functional conservation assessment:
Biochemical divergence despite sequence similarity
Different physiological roles in various species
Context-dependent functionality based on other redox systems present
Approach: Develop a standardized activity assay panel to test recombinant proteins from multiple species. Use complementation studies by expressing HI_1115 orthologs in H. influenzae HI_1115 knockout strains.
3. Structural comparison limitations:
Few solved structures for thioredoxin-like proteins from respiratory pathogens
Difficulty in crystallizing membrane-associated or transient conformations
Subtle structural differences with major functional implications
Approach: Combine homology modeling with targeted experimental structure determination of key representatives. Use molecular dynamics simulations to explore conformational flexibility.
4. Horizontal gene transfer (HGT) analysis:
Confounding phylogenetic signals due to HGT events
Recombination between closely related species creating chimeric sequences
Different selection pressures in various host environments
Approach: Apply reconciliation methods that compare gene trees with species trees to identify HGT events. Use codon-based selection analyses to detect signatures of selection.
5. Data presentation and interpretation:
Complex evolutionary patterns difficult to visualize
Integration of sequence, structural, and functional data
Proposed data integration table:
| Species | Sequence Identity to HI_1115 (%) | Active Site Motif | Key Functional Residues Conserved (%) | Complementation Efficiency (%) | Inferred Evolutionary Event |
|---|---|---|---|---|---|
| H. influenzae (reference) | 100 | WCGYCR | 100 | 100 | - |
| H. parainfluenzae | [value] | [motif] | [value] | [value] | [event] |
| H. ducreyi | [value] | [motif] | [value] | [value] | [event] |
| M. catarrhalis | [value] | [motif] | [value] | [value] | [event] |
| [Other species] | [value] | [motif] | [value] | [value] | [event] |
This systematic approach provides a framework for addressing the complex methodological challenges in evolutionary studies of HI_1115, yielding insights into both conserved and divergent features across respiratory pathogens .
When faced with conflicting experimental results during HI_1115 characterization, researchers should employ a systematic troubleshooting and interpretation framework:
1. Methodological variation analysis:
Compare experimental conditions across conflicting studies:
Buffer compositions (pH, ionic strength, reducing agents)
Protein preparation methods (tags, purification protocols)
Assay detection methods and their limitations
Temperature, time, and concentration differences
2. Statistical reassessment:
Evaluate statistical power in each experiment
Consider biological vs. technical replication strategies
Apply appropriate statistical tests for the data type
Consider Bayesian approaches to integrate prior knowledge with new data
3. Protein-specific considerations:
Assess potential for oxidation state variability influencing activity
Check for effects of freeze-thaw cycles on protein integrity
Examine batch-to-batch variation in recombinant protein preparations
Verify correct protein folding using circular dichroism or thermal shift assays
4. Systematic reconciliation approach:
Create a decision matrix weighing evidence from various experiments:
| Hypothesis | Supporting Evidence | Contradicting Evidence | Experimental Conditions | Confidence Level | Next Experiments |
|---|---|---|---|---|---|
| HI_1115 functions as thiol-disulfide oxidoreductase | [list evidence] | [list evidence] | [conditions] | High/Medium/Low | [experiments] |
| HI_1115 interacts with protein X | [list evidence] | [list evidence] | [conditions] | High/Medium/Low | [experiments] |
| HI_1115 contributes to stress response | [list evidence] | [list evidence] | [conditions] | High/Medium/Low | [experiments] |
5. Independent validation:
Design critical experiments addressing specific conflicts
Use orthogonal methods to test key hypotheses
Consider blind experimental design to minimize bias
Collaborate with laboratories using different approaches
6. Integration with broader knowledge:
Compare with data from homologous proteins in related organisms
Contextualize findings within known redox biochemistry principles
Working with recombinant thioredoxin-like proteins presents several common pitfalls that can compromise experimental outcomes. Here's a comprehensive guide to recognizing and avoiding these issues:
1. Oxidation state inconsistencies:
Pitfall: Thioredoxins easily oxidize during purification, leading to variable activity in subsequent assays.
Solution: Purify under reducing conditions (include 1-5 mM DTT or TCEP). Before activity assays, fully reduce an aliquot with excess DTT, then remove reductant using desalting columns in an anaerobic chamber or under nitrogen. Include redox state controls in all experiments .
2. Expression system artifacts:
Pitfall: High-level expression can cause protein misfolding, inclusion body formation, or incorrect disulfide pairing.
Solution: Optimize expression by tuning vector copy number and promoter strength. Consider specialized strains like Origami (DE3) for disulfide formation. Reduce induction temperature to 16-25°C. Validate protein folding using circular dichroism or thermal shift assays .
3. Tag interference:
Pitfall: Affinity tags can alter protein activity, oligomerization, or interactions.
Solution: Compare tagged and tag-cleaved variants. Position tags at both N- and C-termini to determine optimal configuration. Use smaller tags when possible. Include tag-only controls in interaction studies .
4. Buffer composition effects:
Pitfall: Thioredoxin activity is sensitive to pH, ionic strength, and metal contamination.
Solution: Systematically test buffer conditions. Include EDTA (0.1-1 mM) to chelate metal ions. Use high-quality, metal-free reagents. Document complete buffer compositions in publications .
5. Substrate specificity misinterpretation:
Pitfall: Artificial substrates may not reflect physiological targets.
Solution: Use multiple substrates and assay types. Validate with known thioredoxin substrates as positive controls. Develop physiologically relevant assays using potential natural substrates .
6. Data analysis errors:
Pitfall: Improper normalization, baseline corrections, or kinetic analyses.
Solution: Use appropriate enzyme kinetics models. Establish linear ranges for all assays. Include calibration curves with each experiment. Document all data processing steps .
Experimental design checklist to avoid common pitfalls:
By systematically addressing these common pitfalls, researchers can significantly improve the reliability and reproducibility of experiments involving recombinant thioredoxin-like proteins like HI_1115.
Several cutting-edge technologies show promise for elucidating HI_1115's role in bacterial redox homeostasis:
1. Redox-sensitive fluorescent probes and biosensors:
Technology: Genetically encoded redox sensors (roGFP, HyPer) fused to target proteins
Application: Real-time monitoring of HI_1115-mediated redox changes in living bacteria
Advantage: Provides spatial and temporal resolution of redox events in single cells
Implementation: Create H. influenzae strains expressing redox-sensitive reporters in wild-type and HI_1115 knockout backgrounds
2. CRISPR interference (CRISPRi) for dynamic expression control:
Technology: Inducible dCas9-based repression of gene expression
Application: Titrate HI_1115 expression levels to identify threshold effects on redox homeostasis
Advantage: Allows temporal control and partial knockdown rather than complete knockout
Implementation: Design guide RNAs targeting the HI_1115 promoter or coding region with varying efficiencies
3. Chemical genetics approaches:
Technology: Small molecule modulators of protein function with temporal control
Application: Probe HI_1115 function using selective inhibitors or activators
Advantage: Rapid and reversible perturbation of protein function
Implementation: Screen for compounds that specifically target HI_1115 using activity-based assays
4. Advanced mass spectrometry for thiol proteomics:
Technology: Redox-specific chemical labeling coupled with quantitative proteomics
Application: Comprehensive mapping of HI_1115-dependent changes in the bacterial thiol proteome
Advantage: Identifies direct and indirect targets affected by HI_1115 activity
Implementation: Compare thiol oxidation states in wild-type versus HI_1115 mutant strains under various stresses
5. Cryo-electron microscopy for structural dynamics:
Technology: High-resolution structural analysis of protein complexes
Application: Visualize HI_1115 interactions with partner proteins and conformational changes
Advantage: Captures protein complexes in near-native states
Implementation: Analyze HI_1115 complexes with substrate proteins in different redox states
6. Microfluidics and single-cell analysis:
Technology: Droplet-based microfluidics coupled with single-cell sequencing
Application: Examine heterogeneity in redox responses across bacterial populations
Advantage: Reveals stochastic effects and subpopulation behaviors
Implementation: Sort bacteria based on redox state, followed by transcriptomics or proteomics
7. Transformed Recombinant Enrichment Profiling (TREP):
Technology: Combines natural transformation, phenotypic selection, and deep sequencing
Application: Identify genetic interactions with HI_1115 that affect redox homeostasis
Advantage: Discovers unexpected connections between redox systems and other cellular processes
Implementation: Generate libraries of recombinants with varying HI_1115 alleles and select under oxidative stress conditions
These emerging technologies, when applied systematically, promise to revolutionize our understanding of HI_1115's role in bacterial redox homeostasis at molecular, cellular, and population levels.
Advanced structural biology techniques can provide unprecedented insights into HI_1115's catalytic mechanism through multi-dimensional approaches:
1. Time-resolved X-ray crystallography:
Technique: Synchrotron radiation or X-ray free-electron lasers (XFELs) for capturing short-lived reaction intermediates
Expected insights: Visualization of transient conformational changes during catalysis
Implementation strategy: Design crystal systems amenable to substrate diffusion or trigger reactions using light-sensitive reagents
Key advantage: Captures the dynamic nature of catalysis beyond static structures
2. Hydrogen/Deuterium Exchange Mass Spectrometry (HDX-MS):
Technique: Measures solvent accessibility of protein regions through hydrogen/deuterium exchange rates
Expected insights: Identifies conformational changes upon substrate binding and during catalysis
Implementation strategy: Compare exchange patterns between wild-type HI_1115 and catalytic mutants with various substrates
Key advantage: Provides dynamic structural information in solution without crystallization constraints
3. NMR spectroscopy of active site dynamics:
Technique: Solution NMR with selective isotope labeling of active site residues
Expected insights: Movement of catalytic cysteines during redox reactions
Implementation strategy: ^13^C/^15^N labeling of specific residues (WCGYCR motif) to track chemical shift changes during catalysis
Key advantage: Provides atomic-level dynamics in physiologically relevant conditions
4. Molecular dynamics simulations with quantum mechanics/molecular mechanics (QM/MM):
Technique: Computational modeling combining quantum calculations for reactive centers with molecular mechanics for the protein environment
Expected insights: Energetics of transition states and reaction intermediates not accessible experimentally
Implementation strategy: Use experimental structures as starting points for simulations of the complete catalytic cycle
Key advantage: Predicts energy barriers and reaction pathways to complement experimental observations
5. Cryo-electron microscopy of protein-protein complexes:
Technique: Single-particle cryo-EM to determine structures of HI_1115 bound to substrate proteins
Expected insights: Recognition motifs and interaction interfaces determining substrate specificity
Implementation strategy: Stabilize complexes using single-cysteine mutants to form trapped mixed disulfides
Key advantage: Reveals how HI_1115 recognizes and positions target proteins for catalysis
Integrative structural biology approach:
Combine these techniques in a complementary workflow:
| Technique | Primary Information | Secondary Validation | Integration Strategy |
|---|---|---|---|
| X-ray crystallography | High-resolution static structure | Confirm active site configuration | Baseline structure for all other methods |
| HDX-MS | Regional conformational changes | Identify dynamic segments | Guide mutation studies for functional analysis |
| NMR spectroscopy | Active site chemical environment | Track catalytic residues during reaction | Correlate with computational transition states |
| QM/MM simulations | Reaction energetics and pathways | Predict mutations affecting catalysis | Connect structural changes to energy landscapes |
| Cryo-EM | Complex structures and interfaces | Substrate recognition determinants | Understand biological context of catalysis |
This integrated approach would reveal not only what HI_1115 looks like but how it performs its catalytic function through coordinated structural dynamics, providing a comprehensive understanding of its redox biochemistry .